, and the 36-month beta value for KPRX is at -0.18. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price suggested by analysts for KPRX is $12.33, which is $11.85 above the current market price. The public float for KPRX is 7.13M, and currently, shorts hold a 1.02% of that float. The average trading volume for KPRX on August 31, 2023 was 473.42K shares.
The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
KPRX) stock’s latest price update
Kiora Pharmaceuticals Inc. (NASDAQ: KPRX) has seen a decline in its stock price by -7.50 in relation to its previous close of 0.52. However, the company has experienced a -23.04% decline in its stock price over the last five trading sessions. InvestorPlace reported 2023-08-23 that Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is getting a boost on Wednesday after the company revealed new patents in the U.S. and Europe. According to a press release from Kiora Pharmaceuticals, these patents cover the “local ocular delivery of the KIO-100 family of non-steroidal, anti-inflammatory small molecules.
KPRX’s Market Performance
Kiora Pharmaceuticals Inc. (KPRX) has experienced a -23.04% fall in stock performance for the past week, with a -19.15% drop in the past month, and a -76.99% drop in the past quarter. The volatility ratio for the week is 9.65%, and the volatility levels for the past 30 days are at 6.79% for KPRX. The simple moving average for the past 20 days is -12.28% for KPRX’s stock, with a -82.75% simple moving average for the past 200 days.
KPRX Trading at -20.74% from the 50-Day Moving Average
After a stumble in the market that brought KPRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.76% of loss for the given period.
Volatility was left at 6.79%, however, over the last 30 days, the volatility rate increased by 9.65%, as shares sank -14.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.19% lower at present.
During the last 5 trading sessions, KPRX fell by -23.04%, which changed the moving average for the period of 200-days by -92.10% in comparison to the 20-day moving average, which settled at $0.5443. In addition, Kiora Pharmaceuticals Inc. saw -85.98% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for KPRX
The total capital return value is set at -89.17, while invested capital returns managed to touch -104.18. Equity return is now at value -105.80, with -66.50 for asset returns.
Based on Kiora Pharmaceuticals Inc. (KPRX), the company’s capital structure generated 0.93 points at debt to equity in total, while total debt to capital is 0.92.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.
In conclusion, Kiora Pharmaceuticals Inc. (KPRX) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.